Protective protein gene mutations in galactosialidosis.

Four different protective protein cDNA mutations, 146A-->G (Q49R), 193T-->C (W65R), 268-269TC-->CT (S90L), and 1184A-->G (Y395C), were identified in six Japanese galactosialidosis patients with various phenotypic manifestations, and another mutation, 746T-->A (Y249N), in a patient of French-German origin with an atypical clinical course. Y395C was a common mutation in four Japanese patients in infancy and childhood; two juvenile patients were compound heterozygotes of Y395C and another common mutation, SpDEx7, and the other two infants were compound heterozygotes of Y395C and mutant alleles other than SpDEx7. We confirmed these mutations in genomic DNA by direct-sequence analysis or restriction-site analysis. The mutant cDNA clones, transiently expressed in a transformed galactosialidosis cell line, did not restore the secondarily deficient beta-galactosidase or alpha-neuraminidase activity except for the Y249N mutation that expressed some carboxypeptidase activity and restored the two lysosomal enzyme activities. Pulse-chase analysis detected a small amount of the mature form, as well as the precursor, in the cells transfected with the Y249N cDNA. Only precursor proteins were detected, mature proteins not appearing for the other mutant cDNAs.

[1]  H. Galjaard,et al.  The relation between human lysosomal beta-galactosidase and its protective protein. , 1983, The Journal of biological chemistry.

[2]  Yoshiyuki Suzuki,et al.  GMl-gangliosidosis: Abnormalities in biosynthesis and early processing of β-galactosidase in fibroblasts , 1988 .

[3]  N. Galjart,et al.  Expression of cDNA encoding the human “protective protein≓ associated with lysosomal β-galactosidase and neuraminidase: Homology to yeast proteases , 1988, Cell.

[4]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[5]  D. Wenger,et al.  Macular cherry-red spots and myoclonus with dementia: coexistent neuraminidase and beta-galactosidase deficiencies. , 1978, Biochemical and biophysical research communications.

[6]  Y. Kuroda,et al.  A new point mutation of protective protein gene in two japanese siblings with juvenile galactosialidosis , 1992 .

[7]  Y. Gluzman,et al.  Efficient transformation of human fibroblasts by adenovirus-simian virus 40 recombinants , 1984, Molecular and cellular biology.

[8]  N. Galjart,et al.  A mutation in a mild form of galactosialidosis impairs dimerization of the protective protein and renders it unstable. , 1991, The EMBO journal.

[9]  M. Potier,et al.  Deficient lysosomal carboxypeptidase activity in galactosialidosis. , 1990, Biochemical and biophysical research communications.

[10]  W. Sly,et al.  Combined deficiency of beta-galactosidase and neuraminidase: natural history of the disease in the first 18 years of an American patient with late infantile onset form. , 1990, American journal of medical genetics.

[11]  A. Oshima,et al.  Galactosialidosis: simultaneous deficiency of esterase, carboxy-terminal deamidase and acid carboxypeptidase activities. , 1990, Biochemical and biophysical research communications.

[12]  N. Galjart,et al.  Mouse "protective protein". cDNA cloning, sequence comparison, and expression. , 1990, The Journal of biological chemistry.

[13]  H. Galjaard,et al.  Molecular defect in combined beta-galactosidase and neuraminidase deficiency in man. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Y. Suzuki,et al.  Galactosialidosis: a direct evidence that a 46-kilodalton protein restores deficient enzyme activities in fibroblasts. , 1987, Biochemical and biophysical research communications.

[15]  Suzuki Yoshiyuki,et al.  Galactosialidosis (β-galactosidase-neuraminidase deficiency): a possible role of serine-thiol proteases in the degradation of β-galactosidase molecules , 1982 .

[16]  A. Oshima,et al.  Galactosialidosis : clinical and molecular analysis of 19 Japanese patients , 1991 .

[17]  H. Galjaard,et al.  Human placental neuraminidase , 1985 .

[18]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[19]  Yoshiyuki Suzuki,et al.  Acid carboxypeptidase deficiency in galactosialidosis , 1991, Japanese Journal of Human Genetics.

[20]  Yoshiyuki Suzuki,et al.  Japanese-type adult galactosialidosis. A unique and common splice junction mutation causing exon skipping in the protective protein/carboxypeptidase gene.:A Unique and Common Splice Junction Mutation Causing Exon Skipping in the Protective Protein/Carboxypeptidase Gene , 1990 .

[21]  Yamamura Ken-ichi,et al.  Expression vector system based on the chicken β-actin promoter directs efficient production of interleukin-5 , 1989 .

[22]  R. Skidgel,et al.  A peptidase in human platelets that deamidates tachykinins. Probable identity with the lysosomal "protective protein". , 1990, The Journal of biological chemistry.

[23]  H. Galjaard,et al.  Human placental neuraminidase. Activation, stabilization and association with beta-galactosidase and its protective protein. , 1985, European journal of biochemistry.